1 Hyperphosphatemia is probably the most worrisome feature of cinacalcet use in patients with stage 3–4 CKD. High serum phosphorus level has been implicated as one of the main contributors to ...

Chronic kidney disease (CKD) is associated with accelerated ... or reverse vascular calcification as well as those that prevent hyperphosphatemia and hyperparathyroidism is, therefore, required ...

If approved, we look forward to offering OLC to CKD patients on dialysis with hyperphosphatemia.” Hyperphosphatemia is linked to increased mortality risk. Dialysis patients often face a high ...

22 According to the KDIGO guideline, limiting dietary phosphorus intake is recommended for patients with CKD stages 3, 4, and 5 with clinically significant hyperphosphatemia. 1 The dietary ...

Engaging patients in discussions about different phosphate binders and their unique characteristics is key to improving adherence and satisfaction. New therapies that reduce pill size or burden while ...

Chronic kidney disease (CKD) is an umbrella term used ... (excessive calcium), hyperkalemia (excessive potassium), hyperphosphatemia (excessive phosphate), and uremic toxicity (excessive uric ...

Hyperphosphatemia is a common complication in patients with chronic kidney disease (CKD), caused by phosphate retention as kidney function declines. This condition can result in serious outcomes ...

If approved, we look forward to offering OLC to CKD patients on dialysis with hyperphosphatemia.” Hyperphosphatemia is linked to increased mortality risk. Dialysis patients often face a high ...